Computational screening of metalloporphyrin-based drug carriers for antitumor drug 5-fluorouracil.

Antitumor drug Bonding analysis Density functional theory Drug delivery Metalloporphyrin

Journal

Journal of molecular graphics & modelling
ISSN: 1873-4243
Titre abrégé: J Mol Graph Model
Pays: United States
ID NLM: 9716237

Informations de publication

Date de publication:
12 2023
Historique:
received: 30 06 2023
revised: 19 08 2023
accepted: 27 08 2023
medline: 25 9 2023
pubmed: 12 9 2023
entrez: 11 9 2023
Statut: ppublish

Résumé

Developing novel nanoscale carriers for drug delivery is of great significance for improving treatment efficiency and reducing side effects of antitumor drugs. In view of the good biocompatibility and special affinity of porphyrin (PP) molecule to cancer cells, it was used to construct a series of metal-doped M@PP (M = Ca ∼ Zn) materials for the delivery of anticancer drug 5-fluorouracil (5-Fu) in this work. Our results reveal that 5-Fu is tightly adsorbed on M@PP (M = Ca ∼ V, Mn ∼ Co, and Zn) by chemisorption, but is physically adsorbed by M@PP (M = Cr, Ni, and Cu). The calculated electronic properties show that all these 5-Fu@[M@PP] (M = Ca ∼ Zn) complexes have both high stability and solubility. Among these 5-Fu@[M@PP] complexes, the chemical bond formed between 5-Fu and Ti@PP has the strongest covalent characteristic, resulting in the largest adsorption energy of -19.93 kcal/mol for 5-Fu@[Ti@PP]. In particular, 5-Fu@[Ti@PP] has the proper recovery time under the near-infrared light at body temperature, which further suggests that Ti@PP is the best drug carrier for 5-Fu. This study not only reveals the interaction strength and nature between 5-Fu and M@PP, but also confirmed the intriguing potential of Ti@PP as nano-carrier for drug delivery. However, further experimental research should be conducted to verify the conclusion obtained in this work.

Identifiants

pubmed: 37696119
pii: S1093-3263(23)00215-2
doi: 10.1016/j.jmgm.2023.108617
pii:
doi:

Substances chimiques

Metalloporphyrins 0
Drug Carriers 0
Antineoplastic Agents 0
Fluorouracil U3P01618RT

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108617

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Ya-Xing Guo (YX)

Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, The Department of Basic Chemistry, The School of Pharmacy, Fujian Medical University, Fuzhou, 350108, People's Republic of China; School of Pharmacy, China Medical University, Shenyang, Liaoning Province, 110000, People's Republic of China.

Bin Liu (B)

Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, The Department of Basic Chemistry, The School of Pharmacy, Fujian Medical University, Fuzhou, 350108, People's Republic of China.

Wen-Lu Wang (WL)

Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, The Department of Basic Chemistry, The School of Pharmacy, Fujian Medical University, Fuzhou, 350108, People's Republic of China.

Jie Kang (J)

Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, The Department of Basic Chemistry, The School of Pharmacy, Fujian Medical University, Fuzhou, 350108, People's Republic of China.

Jing-Hua Chen (JH)

Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, The Department of Basic Chemistry, The School of Pharmacy, Fujian Medical University, Fuzhou, 350108, People's Republic of China.

Wei-Ming Sun (WM)

Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, The Department of Basic Chemistry, The School of Pharmacy, Fujian Medical University, Fuzhou, 350108, People's Republic of China; School of Chemistry and Materials Science, University of Science and Technology of China, Hefei, Anhui, 230026, People's Republic of China. Electronic address: sunwm@fjmu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs
Humans Male Female Health Knowledge, Attitudes, Practice Middle Aged
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Humans Female Alopecia Breast Neoplasms Middle Aged

Classifications MeSH